REG - Plus500 Ltd - 2025 Annual Report and 2026 Annual General Meeting

Plus500Announcement

20/03/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260320:nRST3777Xa&default-theme=true

RNS Number : 3777X  Plus500 Limited  20 March 2026

 20 March 2026

Plus500 Ltd.

("Plus500", the "Company" or, together with its subsidiaries, the "Group")

 2025 Annual Report and 2026 Annual General Meeting

Plus500, a global multi-asset fintech group operating proprietary
technology-based trading platforms, has today published on its website,
www.plus500.com, its Annual Report for the year ended 31 December 2025 and a
Notice of its 2026 Annual General Meeting ("AGM").

 

In compliance with UK Listing Rule 6.4.1R of the UK Financial Conduct
Authority ("FCA"), copies of these documents have been submitted today to the
FCA's National Storage Mechanism and will shortly be available for inspection
in unedited full text at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

Printed copies of these documents will be posted to shareholders in due
course.

 

The AGM will be held at 09.00 am UK time on Tuesday, 5 May 2026 at the offices
of Panmure Liberum Limited, Ropemaker Place, 25 Ropemaker Street, London EC2Y
9LY.

For further details

 Plus500 Ltd.
   Elad Even-Chen, Chief Financial Officer   +972 4 8189503

   Owen Jones, Head of Investor Relations    +44 (0) 7551 654208

                                             ir@Plus500.com (mailto:ir@Plus500.com)

 DGA Group
   James Styles                              +44 (0) 7510 385554

   Corbin Ellington                          Plus500@dgagroup.com

About Plus500

Plus500 is a global multi-asset fintech group operating proprietary
technology-based trading platforms. Plus500 offers customers a range of
trading products, including OTC ("Over-the-Counter" products, namely Contracts
for Difference (CFDs)), share dealing, as well as futures and options on
futures.

The Group retains operating licences and is regulated in the United Kingdom,
Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the
Seychelles, the United States, Estonia, Japan, the UAE, the Bahamas, Canada,
Colombia and India, and through its OTC product portfolio, offers more than
2,500 different underlying global financial instruments, comprising equities,
indices, commodities, options, ETFs, foreign exchange and cryptocurrencies.
Customers of the Group can trade its OTC products in more than 60 countries
and in 30 languages.

Plus500's trading platforms are accessible from multiple operating systems
(iOS, Android and Windows) and web browsers. Customer care is, and has always
been, integral to Plus500. As such, OTC customers cannot be subject to
negative balances. A free demo account is available on an unlimited basis for
OTC trading platform users and sophisticated risk management tools are
provided free of charge to manage leveraged exposure, and stop losses to help
customers protect profits, while limiting capital losses.

Plus500 was admitted to trading on the London Stock Exchange (LON: PLUS) on 24
July 2013. It was admitted to the Equity Shares in Commercial Companies
("ESCC") Category of the Official List and is a constituent of the FTSE 250
Index and the STOXX Europe 600 Index. Website: www.plus500.com
(http://www.plus500.com/) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSUKVNRNRUOAAR



            Copyright 2019 Regulatory News Service, all rights reserved